). List of genes identified by ChIP-seq that are associated with functional analysis terms in Figure 6A . The gene ontology analysis was performed using The Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources 6.7. ID denotes the Entrez gene ID. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Primer Sequences

RNA extraction
Cardiac tissues were immediately preserved in RNAlater (Ambion AM7020) and stored in -20 o C. Total RNA was isolated from atria and ventricles using Trizol (Invitrogen 15596-026) followed by the RNeasy mini kit (Qiagen 74104).
qRTPCR
Reverse transcription reactions were carried out using the Transcriptor First Strand cDNA Synthesis kit (Roche 04379012001) to make cDNA. Quantitative PCR analysis (qPCR) was performed on ABI OneStep Plus using the FastStart Universal SYBR Green Master Mix (Roche 04913850001) or the Taqman Universal master Mix II (Invitrogen 4440040).
Expression array analysis
The BCM Genomic and RNA Profiling Core Lab performed the probe generation and subsequent microarray hybridization on Affymetrix mouse genome 430 2.0 chips. Acquired raw data was first processed by the GeneSpring GX software using RMA as the summarization algorithm, Quantile for normalization and median of all samples for baseline transformation. The resulting entity list was filtered on expression (50.0 -35272.484) in raw data followed by statistical analysis using Oneway ANOVA with corrected p value cutoff at 0.05, asymptotic for p value computation and BenjaminiHochberg for multiple testing correction. Calculated against the control atria group, entities from the mutant atria and control ventricles having absolute fold change greater than 1.2 were considered differentially expressed. The entity lists were subsequently annotated using Affymetrix annotation and analyzed by Ingenuity Pathways Analysis (Ingenuity Systems, Mountain View, CA).
Histology
Tissues were fixed in 4% paraformaldehyde (pH7.4) at 4°C overnightsubsequemtly embedded in paraffin. Immunohistochemistry was performed as described previously (Wu et al., Mol Endo 2010) . Primary antibodies utilized include the mouse monoclonal anti-COUP-TFII (R&D Systems PP-H7147-00, diution 1:2000), the mouse monoclonal anti-MLC2a (Synaptic Systems 311011, dilution 1:200), the mouse monoclonal antiMLC2v (Synaptic Systems 310011, dilution 1:200), the mouse monoclonal anti-αSMA (Sigma A2547, dilution 1:1000), the mouse monoclonal anti-Isl1 (Developmental Studies Hybridoma Bank 39.4D5, dilution 1:100), the rabbit polyclonal anti-laminin (Sigma L9393, dilution 1:500), rabbit polyclonal anti-phospho-histone H3 (Cell Signaling 9713, dilution 1:200), goat polyclonal anti-Nkx2.5 (Santa Cruz, sc-8697, dilution 1:2000) , mouse monoclonal anti-connexin 40 (US Biological, C7856-03B, dilution 1:200) and rabbit polyclonal anti-CD31 (Abcam, ab28364, 1:200) . Signals were amplified by Vectastain ABC Elite (Vector PK-6100) followed by developing with ImmPACT DAB (Vector SK-4105), TSA kit #22 or TSA kit #25 (Invitrogen).
Electrocardiogram and echocardiogram
For transthoracic echocardiography, mice were anesthetized using 2% isoflurane in 95% O 2 . Body temperature was maintained between 36.5-37.5°C on a heated platform, and ECG and temperature were continuously monitored. Cardiac function was assessed using a VisualSonics VeVo 770 Imaging System (VisualSonics, Toronto, Canada) equipped with high-frequency 30 MHz probe. For programmed electrical stimulation, atrial and ventricular intracardiac ECG were recorded using a 1.1F octapolar electrode catheter (EPR-800, Millar Instruments, Houston, Texas) inserted into the right ventricle via the right jugular vein. AF inducibility was determined using rapid atrial pacing. All continuous variables are represented as mean ± SEM and categorical variables as percentages. 2-tailed t-test was used to compare the continuous variables and a Fisher's exact test for comparing categorical variables.
Ventricular and atrial cell action potential recordings
For clamp recordings, gigaohm seal were achieved with pipettes fashioned from borosilicate glass with resistances of 3-3.5MΩ. For action potential (AP) recordings, the pipettes were backfilled with solution (mM): potassium aspartate, K-aspatate 120, KCl 20, Na 2 ATP 5, CaCl 2 1.8, Hepes 10, PH 7.4 with KOH. The external solution contained (mM): NaCl 137, KCl 2 , CsCl 3.4, MgCl 2 1, Hepes 10, Glucose 10. pH 7.4 with NaOH. APs were recorded from the clear striated ventricular and atrial cells of each mouse using the amplifier (Axon 200B, Foster city, CA) and digidata converter (1332A A/D, Foster city, CA) at 25kHz. Only cells with above 500MΩ sealing resistance were used for recording by injecting 0.5-0.6nA pulse (1Hz) at 5ms duration. After action potential steady-state upon 5 pulse train pacings were achieved, the rest of 5 APs were used for analysis.
T-tubule imaging and analysis
T-tubules of atrial and ventricular myocytes were visualized by di-8-aminoaphthylethenylpyridinium (di-8-ANEPPS) staining (10 μm for 12 min) in normal Tyrode solution with 1.8 mM Ca 2+ after removal from removal from KB solution. Quantitative analysis of spatial integrity of T-tubules was modified from previous studies (van Oort et al., 2011) and was performed with Image J Data Acquisition software (National Institutes of Health, Bethesda, MD). Region of interest was selected within a cell and outside of nucleus. Power spectrum was computed using Fast Fourier Transform (FFT). Normalized power at spatial frequency of ~0.5 μm -1 normalized to average power at spatial frequency of 0.2 to 0.4 μm -1 ) was used as an index of the spatial integrity of Ttubules (TT-power).
Cell Culture and Luciferase Reporter Assay HL-1 atrial cardiomyocytes were cultured in Claycomb medium (sigma) supplemented with FBS and essential components as previously described (Claycomb et al., 1998) . For luciferase assay, indicated reporter vectors were transfected into HL-1 cells in 6-well plates with lipofectamine 2000 (invitrogen) according to the manufacturer's instruction. Transfected cells were lysed 48 hours after transfection with 1X reporter lysis buffer (promega) and one tenth of the cell lysates was assayed for luciferase activity (promega). The reading was recorded with Centro LB 960 plate reader (Berthold technologies).
Measurement of cell size of a cardiomyocyte
We utilized the area measurement tool in the Zeiss AxioVision software to measure the area of myocardium that is demarcated by laminin staining, followed by counting the number of Nkx2.5-positive cells within the given area. Then the estimated cell size of a cardiomyocyte is calculated from the area size divided by the number of Nkx2.5 positive cells.
